In-Ho Chae

Showing 1-4 of 4 articles

BioMatrix versus Orsiro biodegradable polymer stents in all-comer patients with coronary artery disease: the multicentre, randomised BIODEGRADE trial

Yoon C, Choi Y, Park J, Kang S, Kim S, Suh J, Cho Y, Youn T, Kim M, Cha K, Lee S, Hong B, Rha S, Kang W, Lee J, Kim S, Chae I

April 20, 2021 | 10.4244/EIJ-D-20-00185

Clinical outcomes of long stenting in the drug-eluting stent era: patient-level pooled analysis from the GRAND-DES registry

Kong M, Han J, Kang J, Zheng C, Yang H, Park K, Kang H, Koo B, Chae I, Kim H

March 19, 2021 | 10.4244/EIJ-D-19-00296

Stents and scaffolds

Long-term safety of bioresorbable scaffolds: insights from a network meta-analysis including 91 trials

Kang S, Gogas B, Jeon K, Park J-S, Lee W, Yoon C, Suh J, Hwang S-S, Youn T, Chae I, Kim H

March 20, 2018 | 10.4244/EIJ-D-17-00646

Coronary interventions

Angiographic outcomes of Orsiro biodegradable polymer sirolimus-eluting stents and Resolute Integrity durable polymer zotarolimus-eluting stents: results of the ORIENT trial

Kang S, Chung W-Y, Lee J, Park J, Yoon C, Suh J, Cho Y, Doh J, Cho J, Bae J-W, Youn T, Chae I

January 20, 2017 | 10.4244/EIJ-D-16-00179

1

Latest news

Robotics, AI and Imaging State of The Art; Bleeding Risk and Mortality in CAD; Treating Refractory Angina by Coronary Sinus Narrowing; and more

September 20, 2021

STATE OF THE ART

Robotics, imaging, and artificial intelligence in the catheterisation laboratory

Rafael Beyar et al.

September 20, 2021

ViV TAVI vs repeat SAVR

Monil Majmundar et al.

September 15, 2021

Thrombectomy for ischaemic stroke

Christopher A. Rajkumar et al.

September 10, 2021

Walking the tightrope between ischaemia and bleeding

Michelle L. O’Donoghue et al.

September 20, 2021

Microvascular dysfunction endotypes and outcomes

Christos V. Bourantas et al.

September 20, 2021

Coronary sinus reducer therapy for refractory angina: is it ready for prime time?

Michael Foley et al.

September 20, 2021

Valvular disease